期刊文献+

四氧化四银药用研究进展 被引量:2

Clinical therapeutic application of tetrasilver tetroxide
下载PDF
导出
摘要 四氧化四银(Ag4O4)是一种具有独特构象的“多价银”氧化物,它能与蛋白质表面裸露的N基和S基发生氧化还原反应,从而产生致使蛋白质构象改变的电杀作用和螯合作用。其作用机制不同于一般的抗微生物制剂,作用方式不易引起病原体产生耐药性或突变,对正常组织未见毒性,具有抗微生物和杀伤病变细胞的作用。Ag4O4有望成为一种新型的抗微生物制剂并应用于艾滋病、癌症等疾病的治疗。 Tetrasilve tetroxide(Ag_4O_4)is a multivalent silver oxide with uniq ue configuration. It could react with naked nitrogen and sulfur groups involving oxidation-reduation reaction and resulting in electrocition and chelating reac tion with production of porotein configuration change which would not induce the development of resistant strains of pathogens as many antibiotics just on the co ntrary. Tetrasilve tetroxide has anti-microbial e ff ects and can induce death of cancer cells but it seems non-toxic to normal tiss u e. Thus, tetrasilve tetroxide possesses the potential to be developed as a new anti-microbial, anti-HIV or anti-neoplastic agent.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2005年第7期565-568,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 抗HIV药 抗肿瘤药 药物疗法 电子跃迁化合物 四氧化四银 抗微生物作用 anti-HIV agents anti neoplastic agents drug therapy eletron-jumping compou nds tetrasilver tetroxide anti-microbial
  • 相关文献

参考文献18

  • 1Metabolic solution institute. Silver the healthy metal [ EB/OL]. http:∥www. healthyway. co. za/nutrisil/healthymetal. html, 1999-12-31/2004-03-31.
  • 2FRASER JF, BODMAN J, STURGESS R,et al. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing [J]. Burns, 2004,30 ( 1 ): 35-41.
  • 3BURRELL RE. A scientific perspective on the use of topical silver preparations [J]. Ostomy Wound Manage, 2003,49 ( 5A Suppl ):19 -24.
  • 4SAMUEL E. Silver: the high-priority bacteria fighter [N]. Silver news, 2003 Second quarter:2.
  • 5ANTELMAN MS. Method of treating water employing tetrasilver tetroxide crystals[P]. United States: 5211855,1993-05-18.
  • 6ANTELMAN MS. Method of curing AIDS with tetrasilver tetroxide molecular crystal devices [P]. United States: 5676977,1997-10-14.
  • 7ANTELMAN MS. Tetrasilver tetroxide treatment for skin conditions [P]. United States: 6258385,2001-07-10.
  • 8ANTELMAN MS. Methods of using electron active compounds for managing cancer[P]. United States. 6485755,2002-11-26.
  • 9ANTELMAN MS. Molecular crystal device for pharmaceuticals [P]. United States: 5336499,1994-08-09.
  • 10ANTELMAN MS. Molecular crystal redox device for pharmaceuticals [P]. United States: 5571520,1996-11-05.

同被引文献21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部